Journal of Clinical Oncology

Reply to: Optimizing Control Arms in Chronic Lymphocytic Leukemia Clinical Trials: The BRUIN-CLL-321 Trial

J Jeff P. Sharman (1Willamette Valley Cancer Institute, Sarah Cannon Research, Eugene, OR) B Bin Liu D Denise Y. Wang (Jeff P. Sharman, MD, Willamette Valley Cancer Institute and Research Center, US Oncology Research, Eugene, OR; Bin Liu, MSc, MPH, Denise Y. Wang, PhD, and Ching Ching Leow, PhD Eli Lilly and Company, Indianapolis, IN; and Paul M. Barr, MD, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY) C Ching Ching Leow (21Eli Lilly and Company, Indianapolis, United States) P Paul M. Barr
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 44, Issue 3
Published January 20, 2026
Pages 256-257
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (5)

J

Jeff P. Sharman

1Willamette Valley Cancer Institute, Sarah Cannon Research, Eugene, OR

B

Bin Liu

D

Denise Y. Wang

Jeff P. Sharman, MD, Willamette Valley Cancer Institute and Research Center, US Oncology Research, Eugene, OR; Bin Liu, MSc, MPH, Denise Y. Wang, PhD, and Ching Ching Leow, PhD Eli Lilly and Company, Indianapolis, IN; and Paul M. Barr, MD, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY

C

Ching Ching Leow

21Eli Lilly and Company, Indianapolis, United States

P

Paul M. Barr

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001